CSPC pharmaceutical group buys shares for employee award scheme

On October 16, 2025, CSPC Pharmaceutical Group Limited's Trustee completed an on-market purchase of 4,496,000 shares for its restricted share award scheme. This transaction represents approximately 0.039% of the company's existing total shares in issue.

The shares were acquired at an average price of HK$9.2698 per share, resulting in a total consideration of approximately HK$41,677,000. Following this purchase, the Trustee now holds a balance of 114,000,000 shares on trust for the benefit of selected participants.

The board will continue to periodically assess and determine the number of shares to be awarded to participants, as well as any further on-market purchases under the scheme. This move aligns with the company's previously announced scheme, which was first adopted in August 2018 and subsequently amended in May 2024.